2024 | 2023 | 2022 | 2021 | 2020

»  Look for consumer stories click here

2024

Research Highlights:

• THE CDMRP FUNDS RESEARCH TO ENHANCE TREATMENT AND UNDERSTANDING OF BRAIN METASTASES IN LUNG CANCER

2023

Research Highlights:

• CAR T-cell Therapy for Lung Cancer – Incorporation of Self-Amplification and Safety Mechanisms
• Innovative Drug Combinations to Improve Immunotherapy for the Treatment of Non-Small Cell Lung Cancer

2022

Research Highlights:

• Uncovering the Molecular Drivers of Tuft Cells Provides Insight into Potential Vulnerability in a Variant of Small Cell Lung Cancer
• A New Generation of Researchers: The Lung Cancer Research Program Supports the Development of Early-Career Investigators
• The Lung Cancer Research Program Supports Six Early-Career Investigators with Fiscal Year 2020 (FY20) Awards

2021

Research Highlights:

• Rationalizing New Therapeutic Options for Small Cell Lung Cancer Patients Through a Deeper Understanding of Disease Heterogeneity
• Exploring Modulators of TKI Therapy to Inform Better Patient Treatment for Lung Cancer
• Peripheral Blood T-Cell Dynamic Biomarkers to Identify Responders and Non-Responders in Immune Checkpoint-Based Therapy for Lung Cancer
• LCRP Awardee Receives 2021 Wachtel Cancer Research Award

2020

Research Highlights:

• Investigating Dysbiosis of the Lung as a Biomarker for Early Lung Cancer Detection
• The Generation of Pulmonary Neuroendocrine Cells and SCLC-like Tumors from Human Embryonic Stem Cells
• Lung Cancer Research Program's Career Development Award Expands the Talent Pool in the Field of Lung Cancer
• Targeted Inhibition of Mutant KRAS Oncogene Signaling by RAS Mimetics as a Therapeutic Approach for Lung Cancer
• Predicting Response to Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer
• MEK Inhibition Modulates TNFα Response in Lung Cancer to Enhance Therapeutic Activity

Top of Page